Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
PepsiCo
PEP
|
$199M |
| 2 |
Johnson & Johnson
JNJ
|
$187M |
| 3 |
EMC
EMC CORPORATION
EMC
|
$187M |
| 4 |
Chubb
CB
|
$158M |
| 5 |
Eli Lilly
LLY
|
$135M |
Top Sells
| 1 |
Apple
AAPL
|
$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
$186M |
| 3 |
Comcast
CMCSA
|
$179M |
| 4 |
Pfizer
PFE
|
$165M |
| 5 |
Gilead Sciences
GILD
|
$147M |
Sector Composition
| 1 | Financials | 11.91% |
| 2 | Healthcare | 11.63% |
| 3 | Technology | 11.32% |
| 4 | Industrials | 10.49% |
| 5 | Consumer Staples | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
National Grid
NGG
$70B
| $184M | 0.35% | 2,569,865 +642,265 | +33% | +$45.9M |
|
|
CVC
27
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $183M | 0.35% | 5,554,800 +897,500 | +19% | +$29.6M |
|
|
LSI
28
DELISTED
Life Storage, Inc.
LSI
| $183M | 0.35% | 1,549,800 +72,900 | +5% | +$8.6M |
|
29
Southern Company
SO
$102B
| $180M | 0.34% | 3,473,700 +990,300 | +40% | +$51.2M |
|
30
Crown Castle
CCI
$43.2B
| $179M | 0.34% | 2,074,903 +1,299,800 | +168% | +$112M |
|
31
Costco
COST
$418B
| $175M | 0.33% | 1,110,213 +514,213 | +86% | +$81M |
|
32
Huntington Ingalls Industries
HII
$10.6B
| $174M | 0.33% | 1,270,500 -218,200 | -15% | -$29.9M |
|
33
Herbalife
HLF
$1.01B
| $172M | 0.33% | 2,792,700 +1,873,500 | +204% | +$115M |
|
34
Welltower
WELL
$113B
| $171M | 0.33% | 2,466,000 +381,800 | +18% | +$26.5M |
|
|
JCP
35
DELISTED
J.C. Penney Company, Inc.
JCP
| $165M | 0.31% | 14,922,400 -3,009,800 | -17% | -$33.3M |
|
|
36
Chubb
CB
$110B
| $161M | 0.31% | 1,347,361 +1,327,661 | +6,739% | +$158M |
|
37
Kinross Gold
KGC
$25.5B
| $160M | 0.3% | 47,149,874 +14,107,775 | +43% | +$48M |
|
38
AstraZeneca
AZN
$248B
| $160M | 0.3% | 5,682,800 +723,100 | +15% | +$20.4M |
|
39
Ventas
VTR
$30.9B
| $160M | 0.3% | 2,540,400 -166,600 | -6% | -$10.5M |
|
|
40
Eli Lilly
LLY
$657B
| $159M | 0.3% | 2,213,605 +1,880,800 | +565% | +$135M |
|
41
American Electric Power
AEP
$59.4B
| $155M | 0.29% | 2,332,500 +912,500 | +64% | +$60.6M |
|
42
Palo Alto Networks
PANW
$127B
| $152M | 0.29% | 931,300 -425,700 | -31% | -$69.4M |
|
43
Target
TGT
$43.6B
| $151M | 0.29% | 1,837,200 +1,484,100 | +420% | +$122M |
|
|
FLG
44
Flagstar Financial, Inc.
FLG
$5.33B
| $149M | 0.28% | 9,400,025 +5,125,500 | +120% | +$81.5M |
|
|
VGR
45
DELISTED
Vector Group Ltd.
VGR
| $148M | 0.28% | 6,486,096 +460,865 | +8% | +$10.5M |
|
46
Edwards Lifesciences
EW
$47.8B
| $147M | 0.28% | 1,665,800 +560,700 | +51% | +$49.5M |
|
47
Clorox
CLX
$14.5B
| $145M | 0.28% | 1,153,500 -320,300 | -22% | -$40.4M |
|
48
Annaly Capital Management
NLY
$13.6B
| $141M | 0.27% | 13,768,700 +6,519,800 | +90% | +$66.9M |
|
49
FirstEnergy
FE
$25.2B
| $137M | 0.26% | 3,803,308 +153,300 | +4% | +$5.51M |
|
50
NextEra Energy, Inc.
NEE
$148B
| $137M | 0.26% | 1,155,000 +433,700 | +60% | +$51.3M |
|